WORD MART DISCLAIMED

Brand Owner (click to sort) Address Description
FED MART NEVADA INVESTMENT HOLDINGS, INC. 220 CONGRESS DRIVE DELRAY FL 33445 THE WORD MART IS DISCLAIMED APART FROM THE MARK AS SHOWN.;RETAIL DEPARTMENT AND GROCERY STORE SERVICES;
K MART K MART CORPORATION 3100 WEST BIG BEAVER ROAD TROY MI 48084 THE WORD MART IS DISCLAIMED APART FROM THE MARK AS SHOWN.;FINANCIAL SERVICES-NAMELY, CHECK CASHING;
MAMMOTH MART JAY'S, INCORPORATED 97 EXCHANGE ST. PORTLAND ME THE WORD MART IS DISCLAIMED APART FROM THE MARK AS SHOWN.;DEPARTMENT STORE SERVICES;
MEDI MART STOP & SHOP, INC. 393 D ST. BOSTON MA THE WORD MART IS DISCLAIMED APART FROM THE MARK AS SHOWN.;DRUGSTORE SERVICES AT RETAIL;
QUIK MART CITGO PETROLEUM CORPORATION 1293 Eldridge Parkway Houston TX 77077 The word Mart is disclaimed apart from the mark as shown.;Retail Variety Store Services;
REDI MART Redi Mart, Inc. P.O. Box 787 Richmond KY 40475 The word Mart is disclaimed apart from the mark as shown.;READY MART;Convenience Grocery Store Services;
XTRA MART DRAKE PETROLEUM COMPANY, INC. 800 South Street, Suite 500 Waltham MA 02453 The word Mart is disclaimed apart from the mark as shown.;Gasoline Station Services;EXTRA MART;The drawing is lined for color with the horizontal lines representing blue and the vertical lines representing red.;
XTRA MART WAREX PETROLEUM CORPORATION 355 ALLENS AVE. PROVIDENCE RI 02905 The word Mart is disclaimed apart from the mark as shown.;Gasoline Station Services;EXTRA MART;The drawing is lined for color with the horizontal lines representing blue and the vertical lines representing red.;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma.